Last Price$2.13NASDAQ Previous Close - Last Trade as of 4:15PM ET 10/21/19

Today's Change+0.03(1.67%)
Bid (Size)$2.12 (61)
Ask (Size)$2.16 (80)
Day Low / High$2.06 - 2.43

View Biotechnology IndustryPeer Comparison as of 10/21/2019


OPKO Health Inc ( NASDAQ )

Price: $2.13
Change: +0.03 (1.67%)
Volume: 200.00
4:15PM ET 10/21/2019

Radius Health Inc ( NASDAQ )

Price: $27.33
Change: +0.02 (0.07%)
Volume: 1.2 M
4:00PM ET 10/21/2019

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Eidos Therapeutics Inc ( NASDAQ )

Price: $39.38
Change: -0.01 (0.03%)
Volume: 209.4 K
4:00PM ET 10/21/2019

Coherus BioSciences Inc ( NASDAQ )

Price: $19.18
Change: -0.09 (0.47%)
Volume: 651.0 K
4:00PM ET 10/21/2019

Read more news Recent News

Sector Update: Leading Health Care Stocks Flat To Higher Pre-Bell Monday
9:23AM ET 10/21/2019 MT Newswires

Top Health Care Stocks: JNJ: +0.59% PFE: +0.36% ABT: +0.06% MRK: Flat AMGN: Flat Leading health care stocks were flat to higher pre-bell Monday. Stocks...

Opko, Pfizer Report Positive Phase 3 Results for Somatrogon to Treat Growth-Hormone Deficiency in Children
8:28AM ET 10/21/2019 MT Newswires

Opko Health Inc (OPK) and Pfizer Inc. (PFE) reported that the phase 3 trial evaluating somatrogon in pre-pubertal children with growth-hormone deficiency...

Close Update: US Stocks Close Mixed as Better US PMI Figures Push Back Concerns Over Global Growth Slowdown
4:39PM ET 9/23/2019 MT Newswires

US stocks closed mixed Monday, losing the modest gains secured during midday as investors digested downbeat results of a closely watched survey for the...

Opko Health Says Growth Hormone Deficiency Treatment Shows Favorable Safety Profile After Four Years of Testing
2:46PM ET 9/23/2019 MT Newswires

Shares of Opko Health, Inc. (OPK) were almost 5% higher after the company said its Somatrogon treatment demonstrated a "favorable" safety profile and...

View all Commentary and Analysis

OPKO Health, Inc. (OPK) CEO Phillip Frost on Q2 2019 Results - Earnings Call Transcript
9:31PM ET 8/07/2019 Seeking Alpha

Insider Weekends: Tracy Krohn Buys Shares Of W&T Offshore
11:55AM ET 7/23/2019 Seeking Alpha

Daily Insider Ratings Round Up 7/17/19
6:38AM ET 7/19/2019 Seeking Alpha

Daily Insider Ratings Round Up 7/15/19
11:30AM ET 7/17/2019 Seeking Alpha

Company Profile

Business DescriptionOPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. View company web site for more details
Address4400 Biscayne Boulevard
Miami, Florida 33137
Number of Employees5,690
Recent SEC Filing10/02/2019SC 13D/A
Chairman & Chief Executive OfficerPhillip Frost
Vice Chairman & Chief Technical OfficerJane H. Hsiao
Director & Executive Vice President-AdministrationSteven D. Rubin
Chief Executive Officer-OPKO RenalCharles W. Bishop

Company Highlights

Price Open$2.36
Previous Close$2.13
52 Week Range$1.73 - 3.94
Market Capitalization$1.3 B
Shares Outstanding615.6 M
SectorHealth Technology
Next Earnings Announcement11/08/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.39
Beta vs. S&P 500N/A
Revenue$990.3 M
Net Profit Margin-26.54%
Return on Equity-13.86%

Analyst Ratings as of 03/14/2019

Consensus RecommendationConsensus Icon
Powered by Factset